Work

A Study on Financial Performance of Alkem Pharma

Year: 2025

Type: article

Abstract: This paper evaluates the financial performance of Alkem Laboratories Ltd. over the five-year period from 2019–20 to 2023–24 using key financial ratios. The analysis focuses on profitability, return, liquidity, leverage, and activity ratios to assess the company’s efficiency, stability, and value creation. Findings reveal Alkem’s strong liquidity and low leverage profile, with consistent profitability. However, challenges related to inventory and asset efficiency call for operational improvement. The study is beneficial for investors, analysts, and corporate strategists interested in the pharmaceutical sector.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.17018977

Authors: Gohil Manmeetsinh Sukhdevsinh, Dr. Bhumika Patel

Institution: Monark University

Language: English

Topic: Financial Analysis and Corporate Governance

Subfield: Accounting

Field: Business, Management and Accounting

Domain: Social Sciences

Open Access status: green

OpenAlex ID: W7079712321

FWCI:

Cites:

Cited by:

Related to: